Silexion Therapeutics shareholders approve 6x increase in authorized shares to 9M

Silexion Therapeutics Corp

Authorized capital raised from US$20,000 (1,481,482 shares) to US$121,500 (9,000,000 shares).
Vote results: 699,871 for (59.8%), 470,828 against (40.2%), 289,225 abstentions.
Meeting originally Aug 12, 2025, reconvened Aug 19 after no quorum; 16.8% of shares present constituted quorum under Articles.
Memorandum Amendment filed and effective in Cayman Islands on August 19, 2025.

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.